C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
12/2009
12/09/2009	CN100567242C Hsp90 family protein inhibitors
12/09/2009	CN100566713C Use of of aminosubstituted hydroxybenzophenones as photostable UV-filter in cosmetic and pharmaceutical preparations
12/08/2009	US7629460 Dihydropteridione derivatives, process for their manufacture and their use as medicament
12/08/2009	US7629375 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
12/08/2009	US7629367 Tissue-selective androgen receptor modulators (SARMs); male hypogonadism, prostate cancer, benign prostate hyperplasia, sarcopenia, rheumatoid arthritis and osteoarthritis; N-((5-cyclopropyl-2-fluoropyridin-3-yl)methyl)-2-phenylbutanamide for example
12/08/2009	US7629366 Aminoalcohol derivatives
12/08/2009	US7629343 Carbamic acid compounds comprising a piperazine linkage as HDAC inhibitors
12/08/2009	CA2422342C Novel amide derivatives and medicinal use thereof
12/03/2009	WO2009146255A1 Prostaglandin produgs as hypotensive agents
12/03/2009	WO2009145320A1 Process for producing hydroxyalkyltriethylenediamine compound, and catalyst composition for the production of polyurethane resin using the hydroxyalkyltriethylenediamine compound
12/03/2009	WO2009145219A1 Therapeutic agent for alzheimer's disease
12/03/2009	WO2009143714A1 2,4-dihydroxyl chalcone derivative, process for preparing them and use thereof
12/03/2009	WO2009110002A4 Novel efflux pump inhibitors
12/03/2009	US20090299064 Methods and intermediates for the preparation of optionally radio-labeled imatinib
12/03/2009	US20090299061 Fluorescence assays with improved sensitivity
12/03/2009	US20090298949 Aminoalkylphenols, methods of using and making the same
12/03/2009	US20090298834 4-(aminomethyl)cyclohexanamine derivatives as calcium channel blockers
12/03/2009	CA2729812A1 Therapeutic agent for alzheimer's disease
12/03/2009	CA2726202A1 Process for producing hydroxyalkyltriethylenediamine, and catalyst composition for the production of polyurethane resin using it
12/03/2009	CA2724605A1 Prostaglandin prodrugs as hypotensive agents
12/02/2009	EP2128125A1 Caffeoyl quinic acid derivatives containing nitrogen, and preparation method, pharmaceutically composition and usage thereof
12/02/2009	EP2124933A1 Tosylate salt of a therapeutic compound and pharmaceutical compositions thereof
12/02/2009	EP1490346B1 Stereoselective alkylation of chiral 2-methyl-4-protected piperazines
12/02/2009	CN101591354A Functionalized ionic liquids, and methods of use thereof
12/02/2009	CN101591311A 1-(3-phenyl acryloyl) piperazine derivatives and preparation method thereof
12/02/2009	CN101591310A Method for preparing cinepazide maleate
12/02/2009	CN101591309A Method for preparing 1,1-diphenyl-4 piperidine-1-butylene hydrochloride
12/02/2009	CN101591230A 2,4-dyhydroxyl chalcone derivative, preparation method and application thereof
12/01/2009	US7626042 O-substituted hydroxyaryl derivatives
12/01/2009	US7625948 Ester that inhibits MTP in intestines as antilipemic agents for side effect reduction
12/01/2009	US7625929 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics
12/01/2009	US7625904 Methods for the treatment of sleep disorders
12/01/2009	CA2361802C O-thiocarbamoyl-aminoalkanol compounds, their pharmaceutically acceptable salts and process for preparing the same
11/2009
11/26/2009	WO2009143404A1 Piperazine metabotropic glutamate receptor 5 (mglur5) negative allosteric modulators for anxiety/depression
11/26/2009	WO2009142984A1 Alpha-substituted n-sulfonyl gylcine amides antagonists of ccr10, compositions containing the same and methods for using them
11/26/2009	WO2009142967A1 Therapeutic prostaglandin compounds used as ocular hypotensive agents
11/26/2009	WO2009140765A1 Selective caspase inhibitors and uses thereof
11/26/2009	WO2009035542A3 Guanidine-containing compounds useful as muscarinic receptor antagonists
11/26/2009	US20090291978 Enzyme Inhibitors
11/26/2009	CA2725140A1 Alpha-substituted n-sulfonyl gylcine amides antagonists of ccr10, compositions containing the same and methods for using them
11/26/2009	CA2724785A1 Selective caspase inhibitors and uses thereof
11/26/2009	CA2724474A1 Therapeutic prostaglandin compounds used as ocular hypotensive agents
11/25/2009	EP2123264A1 Heterocyclic derivatives as abnormal cannabidiols agents for lowering intraocular pressure
11/25/2009	EP2121644A2 Improved process for preparing ethyl (s)-2-ethoxy-4-[n-[1-(2- piperidinophenyl)-3-methyl-1-butyl]aminocarbonyl methyl]benzoate and use thereof for the preparation of repaglinide
11/25/2009	EP2121643A2 New process for the preparation of levocetirizine and intermediates thereof
11/25/2009	EP2121634A1 Pyrimidine-2,4-diamine derivatives and their use as jak2 kinase inhibitors
11/25/2009	EP2121590A2 Compounds having aryl-sulphonamidic structure useful as metalloproteases inhibitors
11/25/2009	EP1558595B1 Piperazinyl and diazapanyl benzamides and benzthioamides
11/25/2009	CN100562516C Beta-amyloid protein production/secretion inhibitors
11/25/2009	CN100562513C Benzamide derivative or salt thereof
11/25/2009	CN100562511C 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them
11/24/2009	US7622496 antiarrhythmia agents; 1-(2-Amino-acetyl)-4-(benzoylamino)-pyrrolidine-2-carboxylic acid; desirable bioavailability properties
11/24/2009	CA2385882C Tyrosine derivatives
11/24/2009	CA2385859C 2'-substituted 1,1'-biphenyl-2-carboxamides, processes for their preparation, their use as medicament, and pharmaceutical preparations comprising them
11/19/2009	WO2009138438A1 N- (1, 1, 1, 3, 3, 3-hexafluoro-2-hydroxypropan-2-yl) benzyl-n' -arylcarbonylpiperaz ine derivatives
11/19/2009	WO2009138416A1 Oxime carbamoyl derivatives as modulators of fatty acid amides hydrolase
11/19/2009	US20090286976 One-pot synthesis of fluorinated ionic liquids
11/19/2009	US20090286841 Certain chemical entities, compositions, and methods
11/19/2009	US20090286828 2-amino-1-phenylethylcarboxamide derivatives
11/19/2009	US20090286776 Hexenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof
11/19/2009	US20090286771 2-Phenoxy- and 2-Phenylsulfonamide Derivatives with CCR3 Antagonistic Activity for the Treatment of Inflammatory or Immunological Disorders
11/19/2009	US20090285849 Thiosemicarbazones as anti-virals and immunopotentiators
11/19/2009	CA2723826A1 N- (1, 1, 1, 3, 3, 3-hexafluoro-2-hydroxypropan-2-yl) benzyl-n' -arylcarbonylpiperazine derivatives
11/18/2009	EP2119476A2 Amide derivatives as positive allosteric modulators and methods of use thereof
11/18/2009	EP1768958B1 New disubstituted phenylpiperidines as modulators of dopamine and serotonin neurotransmission
11/18/2009	EP1421071B1 Substituted piperazine and diazepane derivaives as histamine h3 receptor modulators
11/18/2009	EP1370525B1 Biguanide derivatives
11/18/2009	EP1358172B1 Amino ceramide-like compounds and therapeutic methods of use
11/18/2009	CN101583593A Diaryl, dipyridinyl and aryl-pyridinyl derivatives and uses thereof
11/18/2009	CN101583365A Triazine derivatives and their therapeutical applications
11/17/2009	US7619246 Organic light emitting compound and organic light emitting device comprising the same
11/17/2009	US7619115 Ortho-substituted N'-benzylidene-(3-hydroxyphenyl)acethydrazides
11/17/2009	US7619096 3-Aminopyrrolidines as inhibitors of monoamine uptake
11/17/2009	US7619085 Resolution by diastereomeric salt formation and crystallisation is easier to apply industrially; obtain partially enriched mixture of substantially enantiomerically pure (S)-2-[4-(4-chlorobenzhydryl)piperazin-1-yl]-ethoxyacetamide and (R)-2-[4-(4-chlorobenzhydryl)piperazin-1-yl]-ethoxyacetamide
11/17/2009	US7618981 Imidazopyridinyl-benzamide anti-cancer agents
11/17/2009	US7618967 Indane compounds
11/17/2009	CA2463272C Piperazine derivatives with ccr1 receptor antagonist activity
11/17/2009	CA2441239C Mch antagonists and their use in the treatment of obesity
11/12/2009	WO2009137345A1 Therapeutic compounds
11/12/2009	WO2009114742A3 Stable bisthiol compounds for radioimaging and therapy
11/12/2009	US20090281104 Therapeutic Compounds
11/12/2009	US20090281103 Renin Inhibitors
11/12/2009	US20090281066 Treatment of proliferative disorders with amino-substituted (E)-2,6- dialkoxystyryl 4-substituted benzylsulfones
11/12/2009	CA2724972A1 Therapeutic compounds
11/11/2009	EP2114907A2 Piperazine derivatives in cosmetic preparations containing diols
11/11/2009	EP1831189B1 Tetralin and indane derivatives and uses thereof
11/11/2009	EP1742908B1 Non-nucleoside reverse transcriptase inhibitors
11/11/2009	EP1709023B1 Selective estrogen receptor modulators
11/11/2009	EP1566381B1 Process for production of 1- 2-(benzimidazol-2-yl- thio)ethyl piperazine or salts thereof
11/11/2009	CN101578263A Sulfonamides and their use as a medicament
11/11/2009	CN101575321A Trimetazidine and production method of hydrochloride thereof
11/11/2009	CN100558718C Piperazinyl and diazapanyl benzamides and benzthioamides
11/11/2009	CN100558701C N-(2-phenylethyl)sulfamide derivatives as integrin alpha4 antagonists
11/11/2009	CN100558697C Cycloalkyl inhibitors of potassium channel function
11/11/2009	CN100558409C Thiotungstate analogues and uses thereof
11/10/2009	US7615573 Via amino ceramide-like compounds; lowering glycosphingolipid concentrations; Fabry's disease, Gaucher's disease
11/10/2009	US7615563 Compositions useful as inhibitors of voltage-gated sodium channels
11/10/2009	US7615557 Such as 1-(2-Chlorophenyl)-N-(7-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl)piperidine-4-carboxamide; vanilloid receptor antagonists; urological disorders; inflammation; urinary incontinence; benign prostatic hyperplasia
11/10/2009	US7615556 Piperazinyl derivatives as modulators of chemokine receptor activity
11/10/2009	US7615553 E.g., N,N-dimethyl,((5-(hydroxyaminocarbonyl)pyrimidin-2-yl)(piperazin-1,4-ylene)sulfonamide; bioavailability; oral administration; metabolic stability; side effect reduction; psoriasis; anticarcinogenic -proliferative, -arthritic, -inflammatory agent; gene therapy; genetic transcription potentiation

1 ... 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 ... 341